Giovanni Triolo

Summary

Country: Italy

Publications

  1. ncbi Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease
    G Triolo
    Dipartimento Biomedico di Medicina Interna e Specialistica Section of Rheumatology and Clinical Immunology, Policlinico Universitario, Palermo, Italy
    Ann Rheum Dis 61:459-62. 2002
  2. ncbi IVIG in APS pregnancy
    G Triolo
    Sezione di Reumatologia, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy
    Lupus 13:731-5. 2004
  3. ncbi Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease
    Giovanni Triolo
    Department of Internal Medicine, Section of Rheumatology and Clinical Immunology, University of Palermo, Palermo, Italy
    Arthritis Res Ther 5:R262-8. 2003
  4. ncbi Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation
    G Triolo
    Department of Internal Medicine, Rheumatology and Clinical Immunology Unit, Division of Internal Medicine, Department of Pathology, University of Palermo, Italy
    Clin Exp Rheumatol 21:225-8. 2003
  5. ncbi Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies
    Giovanni Triolo
    Cattedra di Reumatologia, Istituto di Clinica Medica, Policlinico and University of Palermo, Palermo, Italy
    Arthritis Rheum 48:728-31. 2003
  6. ncbi Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity
    Antonina Accardo-Palumbo
    Department of Internal Medicine, Division of Rheumatology, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy
    Arthritis Res Ther 12:R109. 2010
  7. ncbi Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis
    Francesco Ciccia
    Universita di Palermo, Palermo, Italy
    Arthritis Rheum 64:1869-78. 2012
  8. ncbi Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients
    Francesco Ciccia
    Department of Internal Medicine, Division of Rheumatology, Piazza delle Cliniche 2, 90127 Palermo, Italy
    Rheumatology (Oxford) 51:1966-72. 2012
  9. ncbi IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis
    Francesco Ciccia
    Department of Internal Medicine, Division of Rheumatology, Piazza delle Cliniche 2, Palermo 90127, Italy
    Ann Rheum Dis 72:258-64. 2013
  10. ncbi Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome
    Francesco Ciccia
    Dipartimento Biomedico di Medicina Interna e Specialistiche, Sezione di Reumatologia, Universita di Palermo, Italy
    Ann Rheum Dis 71:295-301. 2012

Collaborators

Detail Information

Publications28

  1. ncbi Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease
    G Triolo
    Dipartimento Biomedico di Medicina Interna e Specialistica Section of Rheumatology and Clinical Immunology, Policlinico Universitario, Palermo, Italy
    Ann Rheum Dis 61:459-62. 2002
    ..To investigate the humoral and cellular immune response against cow's milk proteins in Behçet's disease and to distinguish any behaviour during active or inactive disease...
  2. ncbi IVIG in APS pregnancy
    G Triolo
    Sezione di Reumatologia, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy
    Lupus 13:731-5. 2004
    ....
  3. ncbi Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease
    Giovanni Triolo
    Department of Internal Medicine, Section of Rheumatology and Clinical Immunology, University of Palermo, Palermo, Italy
    Arthritis Res Ther 5:R262-8. 2003
    ..These results indicate that Vgamma9/Vdelta2 T cell activation is correlated with disease progression and probably involved in the pathogenesis...
  4. ncbi Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation
    G Triolo
    Department of Internal Medicine, Rheumatology and Clinical Immunology Unit, Division of Internal Medicine, Department of Pathology, University of Palermo, Italy
    Clin Exp Rheumatol 21:225-8. 2003
    ..The aim of the study was to assess erythrocyte CD59 expression in patients with psoriatic arthritis in order to understand the role of CD59 in the pathogenesis...
  5. ncbi Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies
    Giovanni Triolo
    Cattedra di Reumatologia, Istituto di Clinica Medica, Policlinico and University of Palermo, Palermo, Italy
    Arthritis Rheum 48:728-31. 2003
    ....
  6. ncbi Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity
    Antonina Accardo-Palumbo
    Department of Internal Medicine, Division of Rheumatology, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy
    Arthritis Res Ther 12:R109. 2010
    ..The aim of this study was to analyse the functional changes of Vgamma9/Vdelta2 T lymphocytes in both active and inactive disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity...
  7. ncbi Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis
    Francesco Ciccia
    Universita di Palermo, Palermo, Italy
    Arthritis Rheum 64:1869-78. 2012
    ..This study was undertaken to evaluate the frequency of NKp44+ NK cells and the expression of IL-22 in the ileum of AS patients...
  8. ncbi Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients
    Francesco Ciccia
    Department of Internal Medicine, Division of Rheumatology, Piazza delle Cliniche 2, 90127 Palermo, Italy
    Rheumatology (Oxford) 51:1966-72. 2012
    ..Conclusion. Our findings suggest IL-32 as an important cytokine probably involved in the innate immune response occurring in early phases of intestinal inflammation, where it seems to play a prevalent protective role...
  9. ncbi IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis
    Francesco Ciccia
    Department of Internal Medicine, Division of Rheumatology, Piazza delle Cliniche 2, Palermo 90127, Italy
    Ann Rheum Dis 72:258-64. 2013
    ..To study the expression of interleukin (IL)-33 and to evaluate its relationship with macrophage polarisation in artery biopsy specimens from patients with giant cell arteritis (GCA)...
  10. ncbi Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome
    Francesco Ciccia
    Dipartimento Biomedico di Medicina Interna e Specialistiche, Sezione di Reumatologia, Universita di Palermo, Italy
    Ann Rheum Dis 71:295-301. 2012
    ..The aim of this study was to investigate the IL-22 expression in the salivary glands of patients with primary Sjögren's syndrome (pSS)...
  11. ncbi Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis
    Francesco Ciccia
    Universita di Palermo, Palermo, Italy
    Arthritis Rheum 63:2097-104. 2011
    ..This study was undertaken to investigate the expression and tissue distribution of IL-32 in artery biopsy specimens from patients with GCA...
  12. ncbi A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease
    Angelo Ferrante
    Dipartimento Biomedico di Medicina Interna e Specialistica, Palermo University School of Medicine, Palermo, Italy
    Clin Exp Rheumatol 28:S27-30. 2010
    ..The aim of the present study was to evaluate the IL-17/IL-23 axis in parallel with Th1 and IL-27 response in the intestine of patients with BD and gastrointestinal abnormalities...
  13. ncbi Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response
    Francesco Ciccia
    University of Palermo, Palermo, Italy
    Arthritis Rheum 62:3625-34. 2010
    ....
  14. ncbi Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation
    Francesco Ciccia
    Dipartimento Biomedico di Medicina Interna e Specialistica, Divisione di Reumatologia, Universita di Palermo, Palermo, Italy
    Rheumatology (Oxford) 49:2076-83. 2010
    ..Here, we investigated the expression of PC-derived peptides in subclinical gut inflammation in AS...
  15. ncbi One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs
    Annarita Giardina
    Chair and Division of Rheumatology, University of Palermo, Palermo, Italy
    Rheumatol Int 31:33-7. 2011
    ..Minor side effects were headache, dizziness, tachycardia that regressed spontaneously and did not entail interruption. Anti-nuclear antibodies were not detected during the period of observation...
  16. ncbi A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
    Anna Rita Giardina
    Division of Rheumatology, Department of Internal Medicine, University of Palermo, Piazza delle Cliniche 2, 90127, Palermo, Italy
    Rheumatol Int 30:1437-40. 2010
    ..Our results are consistent with a significant more rapid clinical improvement in the infliximab treated group. Treatment with both etanercept and infliximab at the end of the study was effective, safe, and well tolerated...
  17. ncbi Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis
    A Ferrante
    Division of Rheumatology, Department of Internal Medicine, University of Palermo, Palermo, Italy
    Rheumatol Int 30:193-8. 2009
    ..Our study indicates that anti-TNF blocking agents, but not methotrexate, are capable of reducing IMT of carotid arteries in female RA patients in a 2-year follow-up...
  18. ncbi No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study
    Anna Rita Giardina
    Dipartimento Biomedico di Medicina Interna e Specialistica, Sezione di Reumatologia, University of Palermo, Palermo, Italy
    Clin Exp Rheumatol 31:25-30. 2013
    ..The aim of our work was to investigate in a two-year prospective study the potential for HBV reactivation in patients with inflammatory joint diseases undergoing anti-TNF treatment from a southern Mediterranean area...
  19. ncbi Successful intravenous immunoglobulin treatment for steroid-resistant eosinophilic enteritis in a patient with systemic lupus erythematosus
    Francesco Ciccia
    Dipartimento Biomedico di Medicina Interna e Specialistica, Universita degli Studi di Palermo, Palermo, Italy
    Clin Exp Rheumatol 29:1018-20. 2011
    ..In this report we describe a case of successful IVIG treatment in a patient with systemic lupus erythematosus and steroid-refractory eosinophilic gastroenteritis...
  20. ncbi Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes?
    Giuliana Guggino
    Dipartimento di Biopatologia e Biotecnologie Mediche e Forensi, Universita degli Studi di Palermo, DIBIMEF, Palermo, Italy
    Clin Dev Immunol 2012:135932. 2012
    ..Here, we summarize the findings of recent investigations on TLR and DcR and their role in the immunopathogenesis of the SLE...
  21. ncbi NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins
    Matilde Todaro
    , Palermo, Italy
    Arthritis Rheum 52:2179-91. 2005
    ..Our results suggest that NF-kappaB plays a crucial role in the pathogenesis of BD, and that its pharmacologic control could represent a key strategy in modulating specific immune-mediated disease...
  22. ncbi New approaches in the treatment of Adamantiades-Behçet's disease
    Nicolo Pipitone
    Unità Operativa di Reumatologia, Arcispedale Santa Maria Nuova, Reggio Emilia, Policlinico Universitario, Palermo, Italy
    Curr Opin Rheumatol 18:3-9. 2006
    ..To update clinicians on the recent advances in the treatment of Adamantiades-Behçet's disease...
  23. ncbi Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis
    Francesco Ciccia
    University of Palermo, Palermo, Italy
    Arthritis Rheum 60:955-65. 2009
    ..This study was undertaken to investigate the expression and tissue distribution of IL-23/Th17-related molecules in Crohn's disease (CD) and in subclinical gut inflammation in ankylosing spondylitis (AS)...
  24. ncbi Cognitive impairment in Behçet's disease patients without overt neurological involvement
    Roberto Monastero
    Department of Neurology and Rehabilitation, Institute of Neuropsychiatry, University of Palermo, Via La Loggia 1, 90129 Palermo, Italy
    J Neurol Sci 220:99-104. 2004
    ..It may occur independently of clinically overt neurological involvement, and is more common in patients with an active disease and in those receiving prednisone...
  25. ncbi Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study
    Luana Mancarella
    Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy
    J Rheumatol 34:1670-3. 2007
    ..To assess the prevalence of good clinical response and remission in rheumatoid arthritis (RA) patients with longstanding disease treated with anti-tumor necrosis factor-alpha (TNF-alpha) drugs at outpatient clinics...
  26. ncbi Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects
    Florenzo Iannone
    Department of Internal Medicine and Public Medicine, Rheumatology Unit, University of Bari, Bari, Italy
    Ann Rheum Dis 66:249-52. 2007
    ..To evaluate the efficacy of switching to etanercept treatment in patients with rheumatoid arthritis who already responded to infliximab, but presented side effects...
  27. ncbi Vascular endothelial growth factor gene polymorphisms in Behçet's disease
    Carlo Salvarani
    Unità di Reumatologia and Laboratorio di Biologia Molecolare, Ospedale di Reggio Emilia, Bologna, Italy
    J Rheumatol 31:1785-9. 2004
    ..To evaluate potential associations of vascular endothelial growth factor (VEGF) gene polymorphisms with Behçet's disease (BD) and disease expression...
  28. ncbi Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis
    Mauro Silingardi
    Ospedale di Reggio Emilia, Regio Emilia, Italy
    Arthritis Rheum 51:177-83. 2004
    ..To evaluate the frequency and type of vascular lesions and to study the association of factor V gene G1691A (Leiden) and prothrombin gene G20210A polymorphisms with venous thrombosis in Italian patients with Behçet's disease (BD)...